Effects of indigestible carbohydrates in barley on glucose metabolism, appetite and voluntary food intake over 16 h in healthy adults

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Johansson, Elin V ^a   Nilsson, Anne C ^a   Östman, Elin M ^a   Björck, Inger M E ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Appetite; Barley; Colonic fermentation; Dietary fibre; Energy intake; GLP 1; Glucose tolerance; Incretins; Inflammation; Metabolic syndrome

Indexed keywords

ADIPONECTIN; CARBOHYDRATE; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INTERLEUKIN 6; MERCURY; STARCH;

ADULT; APPETITE; ARTICLE; BARLEY; BLOOD SAMPLING; BREAD; BREATH ANALYSIS; CALORIC INTAKE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIET RESTRICTION; DIETARY FIBER; FATTY ACID BLOOD LEVEL; FEMALE; FERMENTATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUNGER; INSULIN BLOOD LEVEL; INTESTINE FLORA; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; WHEAT;

ADULT; APPETITE; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FIBER; ENERGY INTAKE; FATTY ACIDS, NONESTERIFIED; FEMALE; GASTROINTESTINAL TRACT; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HORDEUM; HUMANS; HUNGER; INCRETINS; INSULIN; INTERLEUKIN-6; MALE; MEALS; METAGENOME; NUTRITIONAL STATUS; POSTPRANDIAL PERIOD; YOUNG ADULT;

ANIMALIA; HORDEUM; TRITICUM AESTIVUM;

EID: 84875951942     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-46     Document Type: Article

References (54)

1. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Alberti KGMM, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 16681555
2. Diabetes Fact sheet N°312 [ http://www.who.int/mediacentre/ factsheets/fs312/en/index.html ] 23147276
3. Whole grain and fiber consumption are associated with lower body weight measures in US adults: National Health and Nutrition Examination Survey 1999-2004. O'Neil CE, Zanovec M, Cho SS, Nicklas TA, Nutr Res 2010 30 815 822 10.1016/j.nutres.2010.10.013 21147364
4. Whole Grain Consumption and Body Mass Index in Adult Women: An Analysis of NHANES 1999-2000 and the USDA Pyramid Servings Database. Good CK, Holschuh N, Albertson AM, Eldridge AL, J Am Coll Nutr 2008 27 80 87 18460485
5. Whole-grain intake as a marker of healthy body weight and adiposity. Harland JI, Garton LE, Public Health Nutr 2008 11 554 563 18005489
6. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF, Am J Clin Nutr 2002 76 390 398 12145012
7. Fiber and Magnesium Intake and Incidence of Type 2 Diabetes: A Prospective Study and Meta-analysis. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H, Arch Intern Med 2007 167 956 965 10.1001/archinte.167.9.956 17502538
8. Dietary Fiber Intake and Mortality in the NIH-AARP Diet and Health Study. Park Y, Subar AF, Hollenbeck A, Schatzkin A, Arch Intern Med 2011 171 1061 1068 10.1001/archinternmed.2011.18 21321288
9. Relationship between molecular structure of cereal dietary fiber and health effects: focus on glucose/insulin response and gut health. Gemen R, de Vries JF, Slavin JL, Nutr Rev 2011 69 22 33 10.1111/j.1753-4887.2010.00357.x 21198632
10. Whole grains and human health. Slavin J, Nutr Res Rev 2004 17 99 110 10.1079/NRR200374 19079919
11. Food properties affecting the digestion and absorption of carbohydrates. Björck IME, Granfeldt YE, Liljeberg HGM, Tovar J, Asp N-G, Am J Clin Nutr 1994 59 suppl 699S 705S 8116553
12. Cereal grains for nutrition and health benefits: Overview of results from in vitro, animal and human studies in the HEALTHGRAIN project. Björck I, Östman E, Kristensen M, Mateo Anson N, Price RK, Haenen GRMM, Havenaar R, Bach Knudsen KE, Frid A, Mykkänen H, Trends in Food Science & Technology 2012 25 87 100 10.1016/j.tifs.2011.11.005 23588099
13. Evolution of Mammals and Their Gut Microbes. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI, Science 2008 320 1647 1651 10.1126/science.1155725 18497261
14. The impact of nutrition on the human microbiome. Flint HJ, Nutr Rev 2012 70 10 S13 22861801
15. The gut microbiota shapes intestinal immune responses during health and disease. Round JL, Mazmanian SK, Nat Rev Immunol 2009 9 313 323 10.1038/nri2515 19343057
16. Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT, Science 2010 328 228 231 10.1126/science.1179721 20203013
17. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects. Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, Sabico S, O'Hare JP, Ceriello A, Saravanan P, Diabetes Care 2012 35 375 382 10.2337/dc11-1593 22210577
18. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Erridge C, Attina T, Spickett CM, Webb DJ, Am J Clin Nutr 2007 86 1286 1292 17991637
19. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Gut 2009 58 1091 1103 10.1136/gut.2008.165886 19240062
20. Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, Diabetes 2011 60 2775 2786 10.2337/db11-0227 21933985
21. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Cani P, Neyrinck A, Fava F, Knauf C, Burcelin R, Tuohy K, Gibson G, Delzenne N, Diabetologia 2007 50 2374 2383 10.1007/s00125-007-0791-0 17823788
22. Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study. Lutsey PL, Jacobs DR, Kori S, Mayer-Davis E, Shea S, Steffen LM, Szklo M, Tracy R, Br J Nutr 2007 98 397 405 10.1017/S0007114507700715 17391554
23. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. Nilsson AC, Ostman EM, Holst JJ, Bjorck IM, J Nutr 2008 138 732 739 18356328
24. Carbohydrate fermentation decreases hepatic glucose output in healthy subjects. Thorburn A, Muir J, Proietto J, Metabolism 1993 42 780 785 10.1016/0026-0495(93)90249-N 8510524
25. Effect of cereal test breakfasts differing in glycemic index and content of indigestible carbohydrates on daylong glucose tolerance in healthy subjects. Nilsson AC, Ostman EM, Granfeldt Y, Bjorck IM, Am J Clin Nutr 2008 87 645 654 18326603
26. Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Nilsson A, Ostman E, Preston T, Bjorck I, Eur J Clin Nutr 2008 62 712 720 10.1038/sj.ejcn.1602784 17522615
27. Obesity-an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. Torekov SS, Madsbad S, Holst JJ, Obes Rev 2011 12 593 601 10.1111/j.1467-789X.2011.00860.x 21401851
28. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM, Am J Clin Nutr 2009 90 1236 1243 10.3945/ajcn.2009.28095 19776140
29. GLP-1: physiological effects and potential therapeutic applications. Aaboe K, Krarup T, Madsbad S, Holst JJ, Diabetes, Obesity and Metabolism 2008 10 994 1003 10.1111/j.1463-1326.2008.00853.x 18435775
30. In-vivo and in-vitro digestability of starch in autoclaved pea and potatoe products. Björck IME, Siljeström MA, J Sci Food Agric 1992 58 541 553 10.1002/jsfa.2740580414
31. A rapid method for the analysis of starch. Holm J, Björck IME, Drews A, Asp N-G, Starch/Stärke 1986 38 224 226 21533999
32. An in vitro method, based on chewing, to predict resistant starch content in foods allows parallel determination of potentially available starch and dietary fiber. Åkerberg AK, Liljeberg HG, Granfeldt YE, Drews AW, Björck IM, J Nutr 1998 128 651 660 9482777
33. Rapid enzymatic assay of insoluble and soluble dietary fiber. Asp N-G, Johansson C-G, Hallmer H, Siljeström M, J Agric Food Chem 1983 31 476 482 10.1021/jf00117a003 6309935
34. Postprandial Glycemia, Insulinemia, and Satiety Responses in Healthy Subjects after Whole Grain Rye Bread Made from Different Rye Varieties. 2. Rosén LAH, Östman EM, Björck IME, J Agric Food Chem 2011 59 12149 12154 10.1021/jf2019837 21981244
35. Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Wolever TMS, Jenkins DJA, Ocana AM, Rao VA, Collier GR, Am J Clin Nutr 1988 48 1041 1047 2844076
36. Factors related to colonic fermentation of nondigestible carbohydrates of a previous evening meal increase tissue glucose uptake and moderate glucose-associated inflammation. Priebe MG, Wang H, Weening D, Schepers M, Preston T, Vonk RJ, Am J Clin Nutr 2010 91 90 97 10.3945/ajcn.2009.28521 19889821
37. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Cani PD, Hoste S, Guiot Y, Delzenne NM, Br J Nutr 2007 98 32 37 10.1017/S0007114507691648 17367575
38. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM, Diabetes 2012 61 364 371 10.2337/db11-1019 22190648
39. Glucagon-like Peptide 1 Promotes Satiety and Suppresses Energy Intake in Humans. Flint A, Raben A, Astrup A, Holst JJ, J Clin Invest 1998 101 515 520 10.1172/JCI990 9449682
40. A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7-36) Amide on Ad Libitum Energy Intake in Humans. Verdich C, Flint A, Gutzwiller J-P, Naslund E, Beglinger C, Hellstrom PM, Long SJ, Morgan LM, Holst JJ, Astrup A, J Clin Endocrinol Metab 2001 86 4382 4389 10.1210/jc.86.9.4382 11549680
41. Ghrelin enhances appetite and increases food intake in humans. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR, J Clin Endocrinol Metab 2001 86 5992 10.1210/jc.86.12.5992 11739476
42. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Tarini J, Wolever TMS, Applied Physiology, Nutrition & Metabolism 2010 35 9 16 10.1139/H09-119 23473313
43. Glucagon-like peptide-1, glucose homeostasis and diabetes. Holst JJ, Deacon CF, Vilsboll T, Krarup T, Madsbad S, Trends Mol Med 2008 14 161 168 10.1016/j.molmed.2008.01.003 18353723
44. New physiological effects of the incretin hormones GLP-1 and GIP. Asmar M, Dan Med Bull 2011 58 4248 21299928
45. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Zander M, Madsbad S, Madsen JL, Holst JJ, Lancet 2002 359 824 830 10.1016/S0140-6736(02)07952-7 11897280
46. Metabolic cross talk between the colon and the periphery: implications for insulin sensitivity. Robertson MD, Proc Nutr Soc 2007 66 351 361 10.1017/S0029665107005617 17637087
47. Dose-response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo RA, Cusi K, Diabetes 2005 54 1640 1648 10.2337/diabetes.54.6.1640 15919784
48. Inflammation, stress, and diabetes. Wellen KE, Hotamisligil GS, J Clin Invest 2005 115 1111 1119 15864338
49. A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Yannakoulia M, Yiannakouris N, Melistas L, Kontogianni MD, Malagaris I, Mantzoros CS, Metabolism 2008 57 824 830 10.1016/j.metabol.2008.01.027 18502266
50. The role of adiponectin in human vascular physiology. Vaiopoulos AG, Marinou K, Christodoulides C, Koutsilieris M, Int J Cardiol 2012 155 188 193 10.1016/j.ijcard.2011.07.047 21907426
51. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA, J Clin Endocrinol Metab 2001 86 1930 1935 10.1210/jc.86.5.1930 11344187
52. Adiponectin: action, regulation and association to insulin sensitivity. Lihn AS, Pedersen SB, Richelsen B, Obesity Reviews 2005 6 13 21 10.1111/j.1467-789X.2005.00159.x 15655035
53. Pre- and post- prandial appetite hormone levels in normal weight and severely obese women. Carlson J, Turpin A, Wiebke G, Hunt S, Adams T, Nutr Metab 2009 6 32 10.1186/1743-7075-6-32
54. Plasma Adiponectin Increases Postprandially in Obese, but not in Lean, Subjects. English PJ, Coughlin SR, Hayden K, Malik IA, Wilding JPH, Obesity 2003 11 839 844 10.1038/oby.2003.115